⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16473350 | 0.76 | — | — | |
| SCHEMBL11159232 | 0.72 | — | — | |
| SCHEMBL24539550 | 0.71 | — | — | |
| SCHEMBL5404 | 0.70 | — | — | |
| SCHEMBL22118875 | 0.70 | — | — | |
| SCHEMBL2813868 | 0.69 | — | — | |
| SCHEMBL133571 | 0.67 | — | — | |
| SCHEMBL6915362 | 0.67 | — | — | |
| SCHEMBL3252926 | 0.67 | THRB (0.36) | — | |
| Water SCHEMBL8847349 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111233921-A | Novel compound and method for synthesizing fosfomycin impurity D by using same | 上海鼎雅药物化学科技有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-122079984-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079985-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079983-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4719592-A1 | BICYCLIC COMPOUNDS FOR KETOHEXOKINASE INHIBITION | Centennial Therapeutics, LLC (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4709724-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | Jazz Pharmaceuticals Research UK Limited (GB) | 2026-03-18 | — | — | EP | disclosed |
| EP-4658657-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | Mirati Therapeutics, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| US-12410183-B2 | Sars-cov2 main protease inhibitors | GILEAD SCIENCES, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4301468-B1 | FGFR3 INHIBITOR COMPOUNDS | LILLY CO ELI (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4608830-A1 | HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-0892774-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-01-27 | — | — | EP | disclosed |
| EP-0869953-A1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THEREOF | CHONG KUN DANG CORP (KR) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997034569-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1996012716-A1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THEREOF | CHONG KUN DANG CORP. (KR) | 1996-05-02 | — | — | WO | disclosed |
| US-4707182-A | Phenoxine-ketal ethers, compositions containing them and the use thereof | CIBA-GEIGY CORPORATION (US) | 1987-11-17 | — | — | US | disclosed |
| US-4576628-A | PLANT SAFENING AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-03-18 | — | — | US | disclosed |
| US-4530716-A | Plant safening agent | CIBA-GEIGY CORPORATION (US) | 1985-07-23 | — | — | US | disclosed |
| EP-0089313-B1 | OXIME ETHERS, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THE OXIME ETHERS AND THEIR USE | CIBA-GEIGY AG (CH) | 1985-05-02 | — | — | EP | disclosed |
| EP-0089313-A1 | Oxime ethers, process for their preparation, compositions containing the oxime ethers and their use | CIBA-GEIGY AG (CH) | 1983-09-21 | — | — | EP | disclosed |
| US-4235824-A | FROM BUTYNE-1, ACROLEIN, AND AN ALCOHOL | NAARDEN INTERNATIONAL N.V. (NL) | 1980-11-25 | — | — | US | disclosed |